Annual CFI
-$47.60 K
+$9800.00+17.07%
31 December 2023
Summary:
Cardiol Therapeutics annual cash flow from investing activities is currently -$47.60 thousand, with the most recent change of +$9800.00 (+17.07%) on 31 December 2023. During the last 3 years, it has fallen by -$17.30 thousand (-57.10%). CRDL annual CFI is now -362.14% below its all-time high of -$10.30 thousand, reached on 31 December 2021.CRDL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$5800.00
-$3100.00-114.81%
30 September 2024
Summary:
Cardiol Therapeutics quarterly cash flow from investing activities is currently -$5800.00, with the most recent change of -$3100.00 (-114.81%) on 30 September 2024. Over the past year, it has dropped by -$1600.00 (-38.10%). CRDL quarterly CFI is now -115.10% below its all-time high of $38.40 thousand, reached on 01 September 2018.CRDL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$18.80 K
-$1600.00-9.30%
30 September 2024
Summary:
Cardiol Therapeutics TTM cash flow from investing activities is currently -$18.80 thousand, with the most recent change of -$1600.00 (-9.30%) on 30 September 2024. Over the past year, it has increased by +$57.90 thousand (+75.49%).CRDL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | -38.1% | +75.5% |
| 3 y3 years | -57.1% | +43.7% | +7.4% |
| 5 y5 years | -349.1% | +96.8% | +92.9% |
CRDL Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -362.1% | +17.1% | +84.2% | -82.5% | +76.3% | |
| 5 y | 5 years | -362.1% | +85.1% | +96.8% | -82.5% | +94.3% | |
| alltime | all time | -362.1% | +85.1% | -115.1% | +96.8% | <-9999.0% | +94.3% |
Cardiol Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5800.00(+114.8%) | -$18.80 K(+9.3%) |
| June 2024 | - | -$2700.00(+3.8%) | -$17.20 K(-2.3%) |
| Mar 2024 | - | -$2600.00(-66.2%) | -$17.60 K(-63.0%) |
| Dec 2023 | -$47.60 K(-17.1%) | -$7700.00(+83.3%) | -$47.60 K(-37.9%) |
| Sept 2023 | - | -$4200.00(+35.5%) | -$76.70 K(-3.3%) |
| June 2023 | - | -$3100.00(-90.5%) | -$79.30 K(+1.9%) |
| Mar 2023 | - | -$32.60 K(-11.4%) | -$77.80 K(+35.5%) |
| Dec 2022 | -$57.40 K(+457.3%) | -$36.80 K(+441.2%) | -$57.40 K(+178.6%) |
| Sept 2022 | - | -$6800.00(+325.0%) | -$20.60 K(-14.5%) |
| June 2022 | - | -$1600.00(-86.9%) | -$24.10 K(+7.1%) |
| Mar 2022 | - | -$12.20 K(<-9900.0%) | -$22.50 K(+118.4%) |
| Dec 2021 | -$10.30 K | - | - |
| Dec 2021 | - | $0.00(-100.0%) | -$10.30 K(-49.3%) |
| Sept 2021 | - | -$10.30 K(<-9900.0%) | -$20.30 K(+28.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $0.00(0.0%) | -$15.80 K(-6.0%) |
| Mar 2021 | - | $0.00(-100.0%) | -$16.80 K(-44.6%) |
| Dec 2020 | -$30.30 K(-90.5%) | -$10.00 K(+72.4%) | -$30.30 K(-61.1%) |
| Sept 2020 | - | -$5800.00(+480.0%) | -$77.80 K(-69.1%) |
| June 2020 | - | -$1000.00(-92.6%) | -$251.50 K(-23.1%) |
| Mar 2020 | - | -$13.50 K(-76.5%) | -$326.90 K(+2.3%) |
| Dec 2019 | -$319.70 K(+2916.0%) | -$57.50 K(-68.0%) | -$319.70 K(+20.1%) |
| Sept 2019 | - | -$179.50 K(+134.9%) | -$266.20 K(+451.1%) |
| June 2019 | - | -$76.40 K(+1112.7%) | -$48.30 K(+185.8%) |
| Mar 2019 | - | -$6300.00(+57.5%) | -$16.90 K(+59.4%) |
| Dec 2018 | -$10.60 K(-52.9%) | -$4000.00(-110.4%) | -$10.60 K(+60.6%) |
| Sept 2018 | - | $38.40 K(-185.3%) | -$6600.00(-85.3%) |
| June 2018 | - | -$45.00 K(<-9900.0%) | -$45.00 K(<-9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | -$22.50 K | - | - |
FAQ
- What is Cardiol Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual CFI year-on-year change?
- What is Cardiol Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly CFI year-on-year change?
- What is Cardiol Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM CFI year-on-year change?
What is Cardiol Therapeutics annual cash flow from investing activities?
The current annual CFI of CRDL is -$47.60 K
What is the all time high annual CFI for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual cash flow from investing activities is -$10.30 K
What is Cardiol Therapeutics annual CFI year-on-year change?
Over the past year, CRDL annual cash flow from investing activities has changed by +$9800.00 (+17.07%)
What is Cardiol Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CRDL is -$5800.00
What is the all time high quarterly CFI for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly cash flow from investing activities is $38.40 K
What is Cardiol Therapeutics quarterly CFI year-on-year change?
Over the past year, CRDL quarterly cash flow from investing activities has changed by -$1600.00 (-38.10%)
What is Cardiol Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CRDL is -$18.80 K
What is the all time high TTM CFI for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is Cardiol Therapeutics TTM CFI year-on-year change?
Over the past year, CRDL TTM cash flow from investing activities has changed by +$57.90 K (+75.49%)